Australia's Neurizon Therapeutics jumps on licensing agreement with Elanco
ReutersJul 2, 2025 2:30 AM
Shares of Neurizon Therapeutics NUZ.AX rise as much as 3.2% to A$0.160, their biggest intraday pct gain since June 26
The biotechnology co enters into a global licensing agreement with Elanco Animal Health ELAN.N
Agreement is for exclusive rights to Elanco's data package and related intellectual property for Monepantel, the active pharmaceutical ingredient in co's NUZ-001, a formulation used in neurodegeneration applications
YTD, shares of co down 5.9%
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
The Magnificent Seven: What They Are, How They Performed in 2025, and Which Will Be the Best in 2026?
TradingKey - The Magnificent Seven refers to the seven best tech stocks in 2023. These are Apple (AAPL), Microsoft (MSFT), Alphabet (GOOG) (GOOGL), Amazon (AMZN), Nvidia (NVDA), Meta Platforms (META), and Tesla (TSLA). These technology titans are developing products related to Artificial IntelligencTradingKey
an hour ago
Bitcoin Price Prediction 2029-2035: Institutional Accumulation and the U.S. Treasury’s Strategic Reserve Pivot
Explore the 2026 Bitcoin landscape: From the U.S. Strategic Reserve and Michael Saylor’s $75B war chest to Cathie Wood’s 2030 forecast. Is BTC the new Digital Gold?TradingKey
Fri, Feb 13
Is SaaS Dead? The Truth Behind the Software Meltdown, the Missing Floor, and the Peak That’s Not Coming Back
TradingKey - A trillion dollars just vanished from software stocks—this piece breaks down who AI is really killing, who quietly benefits, and why cheap SaaS may be the biggest value trap of this cycle.TradingKey
Thu, Feb 12
USD Dollar Trend Forecast: Dollar Index Falls Below 97.0 to 4-Year Low, Will the Dollar Continue To Fall or Bottom Out in 2026?
TradingKey - In January 2026, the US Dollar Index continued its downward trend from 2025, officially breaking below the key 97.0 level and reaching a low of 95.5, marking a nearly four-year low since February 2022.TradingKey
Fri, Jan 30
